Helix Nanotechnologies
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- Undisclosed
Investors
- 2
About Helix Nanotechnologies
D., Geoffrey Siwo, and Carina Namih, Helix Nanotechnologies, Inc. operates as a provider of mRNA technologies, vaccines, and therapies to pharmaceutical companies and healthcare providers focusing on immune system enhancement and disease prevention. In April 2024, Helix Nanotechnologies, Inc. The company’s core offerings include advanced mRNA therapeutics that target specific pathogens and diseases, alongside innovative vaccine solutions aimed at addressing public health challenges such as infectious diseases and potentially cancer. Helix Nanotechnologies, Inc. serves a diverse clientele that includes healthcare institutions, research organizations, and pharmaceutical companies across North America, Europe, and parts of Asia, with a focus on markets that prioritize advanced biotechnology solutions. Helix Nanotechnologies, Inc. plans to launch new mRNA therapeutics and vaccine solutions in the upcoming year, targeting release dates aligned with ongoing clinical trials. They aim to expand their market presence into Europe and parts of Asia by the end of 2025.
Who invested in Helix Nanotechnologies
2 investors across 1 round
See all investors in Helix Nanotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 4, 2024
Amount
Undisclosed
Investors
Questions about Helix Nanotechnologies
Who invested in Helix Nanotechnologies?
Helix Nanotechnologies has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Helix Nanotechnologies raised?
Helix Nanotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Helix Nanotechnologies last raise money?
Helix Nanotechnologies's most recent round on record is a Series A, in Apr 2024.
What does Helix Nanotechnologies do?
Helix Nanotechnologies is a biotechnology company.
Where is Helix Nanotechnologies headquartered?
Helix Nanotechnologies is headquartered in Boston, US.
Which VCs invest in companies like Helix Nanotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Helix Nanotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Helix Nanotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.